R&D Costs and Returns to New Drug Development: A Review of the Evidence

dc.contributor.author

DiMasi, Joseph A.

dc.contributor.author

Grabowski, HG

dc.date.accessioned

2013-05-13T17:32:46Z

dc.date.issued

2012-09-18

dc.description.abstract

© 2012 by Oxford University Press. All rights reserved.This article reviews the extensive literature on R&D costs and returns. The first section focuses on R&D costs and the various factors that have affected the trends in real R&D costs over time. The second section considers economic studies on the distribution of returns in pharmaceuticals for different cohorts of new drug introductions. It also reviews the use of these studies to analyze the impact of policy actions on R&D costs and returns. The final section concludes and discusses open questions for further research.

dc.identifier.isbn

9780199968749

dc.identifier.uri

https://hdl.handle.net/10161/7342

dc.publisher

OUP USA

dc.relation.ispartof

The Oxford Handbook of the Economics of the Biopharmaceutical Industry

dc.relation.isversionof

10.1093/oxfordhb/9780199742998.013.0002

dc.title

R&D Costs and Returns to New Drug Development: A Review of the Evidence

dc.type

Book section

pubs.organisational-group

Duke

pubs.organisational-group

Economics

pubs.organisational-group

Trinity College of Arts & Sciences

pubs.publication-status

Published

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Econs of Biopharma Indus-Chap2.pdf
Size:
1.73 MB
Format:
Adobe Portable Document Format
Description:
Published version